Yan Su

Title: Innovations by Yan Su: Pioneering Antibody Detection Technologies

Introduction

Yan Su is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative diagnostic tools. With a total of 3 patents, his work focuses on enhancing the accuracy and efficiency of medical testing.

Latest Patents

One of Yan Su's latest patents is a coronavirus antibody detection kit based on magnetic particle chemiluminescence. This novel kit includes streptavidin magnetic particles, biotin-labeled novel coronavirus antigens, an acridine sulfonamide-labeled secondary antibody, a sample diluent, and a quality control material. The kit allows for the qualitative determination of samples by mixing the sample to be tested with the biotin-labeled antigens and streptavidin magnetic particles, followed by incubation and washing. The addition of the acridine sulfonamide-labeled antibody forms a complex that can be detected for luminous intensity.

Another significant patent is the preparation method of Cryptococcus neoformans capsular polysaccharide GXM, along with a GXM antigen immunoassay kit. This method avoids toxic chemical reagents, ensuring operator safety and minimizing environmental pollution. The GXM antigen immunoassay kit is designed for high sensitivity, specificity, repeatability, and stability, providing accurate and reliable results for clinical detection.

Career Highlights

Yan Su has worked with Dynamiker Biotechnology (Tianjin) Co., Ltd., where he has contributed to various innovative projects. His expertise in biotechnology has positioned him as a key player in the development of diagnostic tools that address critical health challenges.

Collaborations

Throughout his career, Yan Su has collaborated with notable colleagues, including Zeqi Zhou and Chunlong Liu. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Yan Su's contributions to biotechnology, particularly in the development of antibody detection technologies, highlight his role as a leading inventor in the industry. His innovative patents reflect a commitment to improving medical diagnostics and ensuring public health safety.